1. Home
  2. DYAI vs CNVS Comparison

DYAI vs CNVS Comparison

Compare DYAI & CNVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DYAI
  • CNVS
  • Stock Information
  • Founded
  • DYAI 1979
  • CNVS 2000
  • Country
  • DYAI United States
  • CNVS United States
  • Employees
  • DYAI N/A
  • CNVS N/A
  • Industry
  • DYAI Biotechnology: Biological Products (No Diagnostic Substances)
  • CNVS Consumer Electronics/Video Chains
  • Sector
  • DYAI Health Care
  • CNVS Consumer Discretionary
  • Exchange
  • DYAI Nasdaq
  • CNVS Nasdaq
  • Market Cap
  • DYAI 54.4M
  • CNVS 56.6M
  • IPO Year
  • DYAI 2004
  • CNVS 2003
  • Fundamental
  • Price
  • DYAI $1.38
  • CNVS $3.15
  • Analyst Decision
  • DYAI Strong Buy
  • CNVS Buy
  • Analyst Count
  • DYAI 1
  • CNVS 1
  • Target Price
  • DYAI $6.00
  • CNVS $10.00
  • AVG Volume (30 Days)
  • DYAI 59.9K
  • CNVS 75.0K
  • Earning Date
  • DYAI 03-26-2025
  • CNVS 02-13-2025
  • Dividend Yield
  • DYAI N/A
  • CNVS N/A
  • EPS Growth
  • DYAI N/A
  • CNVS N/A
  • EPS
  • DYAI N/A
  • CNVS N/A
  • Revenue
  • DYAI $3,495,389.00
  • CNVS $72,469,000.00
  • Revenue This Year
  • DYAI $51.30
  • CNVS $59.61
  • Revenue Next Year
  • DYAI $73.26
  • CNVS N/A
  • P/E Ratio
  • DYAI N/A
  • CNVS N/A
  • Revenue Growth
  • DYAI 20.58
  • CNVS 39.86
  • 52 Week Low
  • DYAI $0.93
  • CNVS $0.72
  • 52 Week High
  • DYAI $2.67
  • CNVS $4.89
  • Technical
  • Relative Strength Index (RSI)
  • DYAI 46.47
  • CNVS 35.44
  • Support Level
  • DYAI $1.29
  • CNVS $3.03
  • Resistance Level
  • DYAI $1.45
  • CNVS $3.65
  • Average True Range (ATR)
  • DYAI 0.10
  • CNVS 0.19
  • MACD
  • DYAI 0.00
  • CNVS -0.03
  • Stochastic Oscillator
  • DYAI 41.38
  • CNVS 15.79

About DYAI Dyadic International Inc.

Dyadic International Inc is a world-wide biotechnology platform company. The company has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins, and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

About CNVS Cineverse Corp.

Cineverse Corp is a main streaming technology and entertainment company. It operates portfolios of owned and operated streaming channels, all powered by its, proprietary technology platform. Cineverse features enthusiast brands for subscription video on demand (SVOD), advertising-based video on demand (AVOD), and free, ad-supported streaming television (FAST) channels. The company earns fees for the distribution of content in the home entertainment markets via several distribution channels, including digital, video-on-demand, and physical goods (e.g., DVDs and Blu-ray Discs) (Base Distribution).

Share on Social Networks: